会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Implantable cardiac stimulation system and method for automatic capture verification calibration
    • 植入式心脏刺激系统和自动捕获验证校准方法
    • US06731985B2
    • 2004-05-04
    • US09981555
    • 2001-10-16
    • John W. PooreKerry BradleyLaurence S. SlomanGene A. BornzinJoseph J. Florio
    • John W. PooreKerry BradleyLaurence S. SlomanGene A. BornzinJoseph J. Florio
    • A61N1362
    • A61N1/3712
    • An implantable cardiac stimulation device and associated method perform an automatic calibration procedure for evaluating whether automatic capture verification can be recommended. The calibration procedure calculates and displays a number of variables for use by a medical practitioner in programming automatic capture operating parameters. An average paced depolarization integral (PDI) is determined from the cardiac signals following delivery of multiple stimulation pulse below and above capture threshold such that both pure lead polarization signals and evoked response signals may be analyzed. From the paced depolarization integral data, a capture threshold, a stimulation response curve, a minimum evoked response, a maximum lead polarization, an evoked response sensitivity, an evoked response safety margin, and a polarization safety margin are determined. Based on these variables, the calibration procedure determines if automatic capture verification can be recommended. If so, the stimulation device calculates a capture detection threshold. The automatic capture verification recommendation and the estimated calibration variables are displayed.
    • 可植入心脏刺激装置和相关方法执行自动校准程序,以评估是否可以推荐自动捕获验证。 校准程序计算并显示许多变量,供医生在编程自动捕获操作参数时使用。 平均节奏去极化积分(PDI)是在多次刺激脉冲传递后低于和高于捕获阈值的心脏信号确定的,以便可以分析纯铅极化信号和诱发响应信号。 从起搏去极化积分数据中,确定捕获阈值,刺激响应曲线,最小诱发响应,最大引线极化,诱发响应灵敏度,诱发响应安全裕度和极化安全裕度。 基于这些变量,校准过程确定是否可以推荐自动捕获验证。 如果是,则刺激装置计算捕获检测阈值。 显示自动捕获验证建议和估计的校准变量。
    • 2. 发明授权
    • Methods and apparatus for preventing atrial arrhythmias by overdrive pacing and prolonging atrial refractoriness using an implantable cardiac stimulation device
    • 使用可植入心脏刺激装置通过过度起搏预防房性心律失常和延长心房不应性的方法和装置
    • US06606517B1
    • 2003-08-12
    • US09548293
    • 2000-04-12
    • Euljoon ParkGene A. BornzinJoseph J. FlorioJohn W. PooreLaurence S. SlomanPeter BoileauDouglas T. Kurschinski
    • Euljoon ParkGene A. BornzinJoseph J. FlorioJohn W. PooreLaurence S. SlomanPeter BoileauDouglas T. Kurschinski
    • A61N1362
    • A61N1/3622
    • A method and apparatus for reducing the incidence of atrial arrhythmias by using an overdrive algorithm to determine the application of overdrive stimulation pulses to a patient's heart, e.g., in the atria. In a first aspect of the invention, the apparatus first determines an overdrive pacing rate and then applies pairs of temporally spaced (staggered) pacing pulses, i.e., primary and secondary pacing pulses, at the determined overdrive pacing rate. In a further aspect of the invention, the pairs of pacing pulses are applied at the overdrive pacing rate to multiple spatially spaced electrodes, i.e., electrodes distributed among multiple sites in a patient's heart, e.g., in the atria. In accordance with a first preferred embodiment, the electrodes may be distributed within a single atrium, e.g., the right atrium, of the patient's heart. Alternatively, a first electrode may be placed in the right atrium and a second electrode may be placed in the coronary sinus or the left atrium or multiple electrodes may be placed proximate to the left atrium. Furthermore, the invention relates to techniques for controlling overdrive pacing to multiple sites in a patient's heart so as to achieve and maintain a target degree of pacing and thus suppress tachycardias.
    • 一种用于通过使用过驱动算法来确定过度驱动刺激脉冲施加到患者心脏(例如在心房)中来减少心房心律失常发生率的方法和装置。 在本发明的第一方面中,装置首先确定过驱动起搏速率,然后以确定的超速起搏速率施加时间间隔(交错)的起搏脉冲,即初级和次级起搏脉冲。 在本发明的另一方面,以超速起搏速率将多对起搏脉冲施加到多个空间间隔开的电极,即分布在患者心脏中的多个部位之间的电极,例如在心房中。 根据第一优选实施例,电极可以分布在患者心脏的单个心房(例如右心房)内。 或者,第一电极可以放置在右心房中,并且第二电极可以放置在冠状窦或左心房中,或者多个电极可以放置在靠近左心房的位置。 此外,本发明涉及用于控制对患者心脏中的多个部位的超速起搏的技术,以便实现和维持目标起搏程度,从而抑制心动过速。
    • 5. 发明授权
    • Implantable cardiac stimulation device and method for prolonging atrial refractoriness
    • 植入式心脏刺激装置及延长心房不应性的方法
    • US06701187B1
    • 2004-03-02
    • US10061567
    • 2002-02-01
    • Gene A. BornzinLaurence S. SlomanPeter BoileauJoseph J. Florio
    • Gene A. BornzinLaurence S. SlomanPeter BoileauJoseph J. Florio
    • A61N1362
    • A61N1/3622A61N1/3956
    • An implantable cardiac stimulation device, e.g., a pacemaker or an implantable cardioverter defibrillator (ICD), is provided which prolongs the atrial refractoriness of a heart. The implantable cardiac stimulation device includes a generator that delivers pacing pulses to an atrium of a heart and a detector that detects atrial activations of the heart. An inhibitor is coupled to the detector that inhibits the generator when an atrial activation is detected within an escape interval. A generator control coupled to the generator causes the generator to deliver a primary pacing pulse to the atrium at the end of the escape interval, absent an atrial activation being detected within the escape interval, and causes the generator to deliver a secondary pacing pulse to the atrium a delay time after an atrial activation is detected within the escape interval or the delivery of a primary pacing pulse to the atrium.
    • 提供可植入心脏刺激装置,例如起搏器或植入式心律转复除颤器(ICD),其延长心脏的心房不应性。 可植入心脏刺激装置包括将起搏脉冲传送到心脏心房的发生器和检测心脏心房激活的检测器。 当在逃避间隔内检测到心房激活时,抑制剂耦合到检测器,该检测器抑制发生器。 耦合到发生器的发生器控制器使得发生器在逃逸间隔结束时将主起搏脉冲递送到心房,没有在逃逸间隔内检测到心房激活,并且使得发生器将辅助起搏脉冲输送到 在转移间隔内检测到心房激活之后的延迟时间或者向心房传送初级起搏脉冲。
    • 6. 发明授权
    • Implanatable cardiac stimulation device and method for prolonging atrial refractoriness
    • 可手术心脏刺激装置及延长心房不应性的方法
    • US06377852B1
    • 2002-04-23
    • US09488284
    • 2000-01-20
    • Gene A. BornzinLaurence S. SlomanPeter BoileauJoseph J. Florio
    • Gene A. BornzinLaurence S. SlomanPeter BoileauJoseph J. Florio
    • A61N1362
    • A61N1/3622A61N1/3956
    • An implantable cardiac stimulation device, e.g., a pacemaker or an implantable cardioverter defibrillator (ICD), is provided which prolongs the atrial refractoriness of a heart. The implantable cardiac stimulation device includes a generator that delivers pacing pulses to an atrium of a heart and a detector that detects atrial activations of the heart. An inhibitor is coupled to the detector that inhibits the generator when an atrial activation is detected within an escape interval. A generator control coupled to the generator causes the generator to deliver a primary pacing pulse to the atrium at the end of the escape interval, absent an atrial activation being detected within the escape interval, and causes the generator to deliver a secondary pacing pulse to the atrium a delay time after an atrial activation is detected within the escape interval or the delivery of a primary pacing pulse to the atrium.
    • 提供可植入心脏刺激装置,例如起搏器或植入式心律转复除颤器(ICD),其延长心脏的心房不应性。 可植入心脏刺激装置包括将起搏脉冲传送到心脏心房的发生器和检测心脏心房激活的检测器。 当在逃避间隔内检测到心房激活时,抑制剂耦合到检测器,该检测器抑制发生器。 耦合到发生器的发生器控制器使得发生器在逃逸间隔结束时将主起搏脉冲递送到心房,没有在逃逸间隔内检测到心房激活,并且使得发生器将辅助起搏脉冲输送到 在转移间隔内检测到心房激活之后的延迟时间或者向心房传送初次起搏脉冲。
    • 7. 发明授权
    • System and method of identifying fusion for dual-chamber automatic capture stimulation device
    • 识别双室自动捕获刺激装置融合的系统和方法
    • US06904321B1
    • 2005-06-07
    • US10208169
    • 2002-07-29
    • Gene A. BornzinJoseph J. FlorioLaurence S. Sloman
    • Gene A. BornzinJoseph J. FlorioLaurence S. Sloman
    • A61N1/37A61N1/36
    • A61N1/3712
    • A multi-chamber stimulation device and associated method reliably and automatically distinguish fusion from loss of capture during ventricular stimulation. The stimulation device provides immediate and accurate fusion detection when a loss of capture is suspected in the ventricles without delivering back-up stimulation pulses. To achieve this objective, the far-field signal present in the atrial channel is examined for evidence of a far-field R-wave whenever the ventricular channel detects a loss of capture. If a far-field R-wave is present, fusion is confirmed, and a far-field R-wave is absent, loss of capture is confirmed. Additionally, the stimulation device inhibits unnecessary back-up stimulation and threshold tests when fusion occurs, and provides appropriate adjustment of stimulation parameters based on confirmed fusion detection such that fusion re-occurrence is minimized.
    • 多室刺激装置和相关方法可靠和自动地将融合与心室刺激期间的捕获损失区分开来。 刺激装置提供即时和准确的融合检测,当脑袋怀疑丢失而不输送备用刺激脉冲时。 为了达到这个目的,每当心室通道检测到捕获的丢失时,都会检查存在于心房通道中的远场信号以获得远场R波的证据。 如果存在远场R波,则确认融合,并且不存在远场R波,确认捕获损失。 此外,当融合发生时,刺激装置抑制不必要的后备刺激和阈值测试,并且基于确认的融合检测提供刺激参数的适当调整,使得融合再现最小化。
    • 9. 发明授权
    • System and method of identifying fusion for dual-chamber automatic capture stimulation device
    • 识别双室自动捕获刺激装置融合的系统和方法
    • US06456881B1
    • 2002-09-24
    • US09630771
    • 2000-08-02
    • Gene A. BornzinJoseph J. FlorioLaurence S. Sloman
    • Gene A. BornzinJoseph J. FlorioLaurence S. Sloman
    • A61N136
    • A61N1/3712
    • A multi-chamber stimulation device and associated method reliably and automatically distinguish fusion from loss of capture during ventricular stimulation. The stimulation device provides immediate and accurate fusion detection when a loss of capture is suspected in the ventricles without delivering back-up stimulation pulses. To achieve this objective, the far-field signal present in the atrial channel is examined for evidence of a far-field R-wave whenever the ventricular channel detects a loss of capture. If a far-field R-wave is present, fusion is confirmed, and a far-field R-wave is absent, loss of capture is confirmed. Additionally, the stimulation device inhibits unnecessary back-up stimulation and threshold tests when fusion occurs, and provides appropriate adjustment of stimulation parameters based on confirmed fusion detection such that fusion re-occurrence is minimized.
    • 多室刺激装置和相关方法可靠和自动地将融合与心室刺激期间的捕获损失区分开来。 刺激装置提供即时和准确的融合检测,当脑袋怀疑丢失而不输送备用刺激脉冲时。 为了达到这个目的,每当心室通道检测到捕获的丢失时,都会检查存在于心房通道中的远场信号以获得远场R波的证据。 如果存在远场R波,则确认融合,并且不存在远场R波,确认捕获损失。 此外,当融合发生时,刺激装置抑制不必要的后备刺激和阈值测试,并且基于确认的融合检测提供刺激参数的适当调整,使得融合再现最小化。
    • 10. 发明申请
    • SYSTEMS AND METHODS FOR ASSESSING HEART FAILURE AND CONTROLLING CARDIAC RESYNCHRONIZATION THERAPY USING HYBRID IMPEDANCE MEASUREMENT CONFIGURATIONS
    • 用于评估心脏衰竭和控制使用混合阻抗测量配置的心脏再生治疗的系统和方法
    • US20130053912A1
    • 2013-02-28
    • US13217554
    • 2011-08-25
    • Gene A. BornzinXiaoyi MinLaurence S. SlomanSteve Koh
    • Gene A. BornzinXiaoyi MinLaurence S. SlomanSteve Koh
    • A61N1/368
    • A61B5/053A61B5/0205A61B5/0538A61B5/686A61N1/36185A61N1/3627A61N1/3686
    • Techniques are provided for use with an implantable medical device for detecting and assessing heart failure and for controlling cardiac resynchronization therapy (CRT) based on impedance signals obtained using hybrid impedance configurations. The hybrid configurations exploit right atrial (RA)-based impedance measurement vectors and/or left ventricular (LV)-based impedance measurement vectors. In one example, current is injected between the device case and a ring electrode in the right ventricle (RV) or RA. RA-based impedance values are measured along vectors between the device case and an RA electrode. LV-based impedance values are measured along vectors between the device case and one or more electrodes of the LV. Heart failure and other cardiac conditions are detected and tracked using the measured impedance values. CRT delay parameters are also optimized based impedance. In this manner, multiple hybrid impedance measurement configurations are exploited whereby different vectors are used to inject current and measure impedance.
    • 提供技术用于可植入医疗装置,用于基于使用混合阻抗配置获得的阻抗信号来检测和评估心力衰竭并用于控制心脏再同步治疗(CRT)。 混合配置利用基于右心房(RA)的阻抗测量向量和/或左心室(LV))的阻抗测量向量。 在一个示例中,电流注入到装置壳体和右心室(RV)或RA中的环形电极之间。 基于RA的阻抗值是沿器件壳体和RA电极之间的矢量测量的。 基于LV的阻抗值在器件壳体和LV的一个或多个电极之间的矢量上测量。 使用测量的阻抗值检测和跟踪心力衰竭和其他心脏状况。 CRT延迟参数也是基于阻抗的优化。 以这种方式,利用多个混合阻抗测量配置,由此使用不同的矢量来注入电流并测量阻抗。